Speech-Language Pathologists in North Lauderdale, FL Accepting Medicare
3 Speech-Language Pathologists found. Showing 1 - 3
 Kimberley Coore-powell Fox, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1103 E Jasmine Lane, North Lauderdale, FL 33068 Phone: 954-649-9397 Fax: 954-917-9397 |
Ashley Marin, SZ Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6481 Sw 10th St, North Lauderdale, FL 33068 Phone: 954-330-3354 |
Marliz Crespo, M.S. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 425 Sw 79th Ter, North Lauderdale, FL 33068 Phone: 954-632-1358 |
News Archive
Researchers develop free mobile app to help dementia patients and their families
Want to learn everything there is to know about dementia? There's an app for that. Researchers at the University of Illinois at Chicago College of Nursing have developed a free mobile app for individuals suffering from dementia, their families and caregivers, as a way to improve the quality-of-life, well-being and knowledge of the disease that affects nearly 48 million people worldwide.
AVRF and UPEI collaboration awarded Innovation PEI Pilot and Discovery Fund grant
Atlanta Vascular Research Foundation (AVRF), together with its collaborators at the University of Prince Edward Island (UPEI), has been awarded an Innovation PEI Pilot and Discovery Fund grant by Innovation PEI. The grant is to continue research and development in combining nutraceuticals to magnify clinical benefits for the prevention and treatment of cardiovascular and metabolic diseases. The funding from this grant is $25,000.
Injectable hormonal contraceptive appears to increase HIV risk in women
Women using depot medroxyprogesterone acetate (DMPA), commonly known as Depo-Provera or the birth control shot, have a moderately increased risk of becoming infected with HIV, a large meta-analysis of 12 studies involving more than 39 500 women published in The Lancet Infectious Diseases has found. Other forms of hormonal contraception, including oral contraceptive pills, do not appear to increase this risk.
Study highlights potential tolerability of single fraction of HDR brachytherapy for localized prostate cancer
Results from a new prospective clinical trial indicate that high-dose-rate (HDR) brachytherapy administered in a single, 19 Gray treatment may be a safe and effective alternative to longer courses of HDR treatment for men with localized prostate cancer.
› Verified 7 days ago
Chiropractors
Optometrists
Speech-Language Pathologists
Podiatrists
Physical Therapists
Occupational Therapists